BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8001 related articles for article (PubMed ID: 11436353)

  • 1. Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.
    Ikenaka K; Sasaki M; Tamura K; Tamura M; Miyao Y; Nanmoku K; Kawano Y; Nakahira K; Yoshimine T; Shimizu K
    Hum Cell; 2001 Mar; 14(1):49-58. PubMed ID: 11436353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
    Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
    Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma.
    Sasaki M; Nakahira K; Kawano Y; Katakura H; Yoshimine T; Shimizu K; Kim SU; Ikenaka K
    Cancer Res; 2001 Jun; 61(12):4809-14. PubMed ID: 11406556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene.
    Kuriyama S; Masui K; Kikukawa M; Sakamoto T; Nakatani T; Nagao S; Yamazaki M; Yoshiji H; Tsujinoue H; Fukui H; Yoshimatsu T; Ikenaka K
    Gene Ther; 1999 Apr; 6(4):525-33. PubMed ID: 10476212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
    Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.
    Hlavatý J; Hlubinová K; Altanerová V; Líska J; Altaner C
    Neoplasma; 1997; 44(6):342-7. PubMed ID: 9605005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy.
    Cirenei N; Colombo BM; Mesnil M; Benedetti S; Yamasaki H; Finocchiaro G
    Gene Ther; 1998 Sep; 5(9):1221-6. PubMed ID: 9930323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumors.
    Tamura M; Ikenaka K; Tamura K; Yoshimatsu T; Miyao Y; Kishima H; Mabuchi E; Shimizu K
    Gene Ther; 1998 Dec; 5(12):1698-704. PubMed ID: 10023449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy against an experimental glioma using adeno-associated virus vectors.
    Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
    Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.
    Hlavatý J; Hlubinová K; Bies J; Altaner C
    Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.
    Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K
    J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
    Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
    J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 401.